SBC

DEFA14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

DEF 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026. SBC Medical will deliver webcast presentations and conduct one-on-one meetings with institutional investors. Below is a summary of the Company's scheduled participation in upcoming investor conferences: ConferenceDateTime (ET)FormatLinkLytham Partners– Spring 2026 Investor ConferenceMay 28—1-on-1 MeetingsRegistrationNoble Capital Markets– June 2026 Emerging G

IRVINE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that its consulting partner in Thailand, BLEZ ASIA Co., Ltd. ("BLEZ ASIA") held an inauguration reception on May 21, 2026, to celebrate the opening of a new aesthetic dermatology section at BLEZ CLINIC in the Asok district of Bangkok. The event marks a significant milestone in SBC Medical's efforts to bring high-quality aesthetic healthcare services to the Thai market, with the section's service launch scheduled for June 2026. Thailand'

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2026 / Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its 12-month price target to $10.00 from $9.00, representing significant potential upside from the Company's recent share price of $2.89 as of May 19, 2026.The Quarterly Update highlights SBC's expectation for a return to revenue growth in 2026 following the completion of pricing-related headwinds experienced during 2025, while emphasizing the Company's strong cash position, expanding clinic footprint, and long-term global growth strategy.Key Highlig

PRE 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

10-Q - SBC Medical Group Holdings Inc (0001930313) (Filer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributabl

IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026. Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time. A question‑and‑answer session with analysts and investors will follow the prepared remarks. Please register in advance for the conference using the link provided below.https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTik

10-K/A - SBC Medical Group Holdings Inc (0001930313) (Filer)

4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026.The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.Key Highlights from the Flash Report:Secondary Share Transaction Misinterpreted by Market: SBC recently completed a secondary share issuan

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("the Company"), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the "Selling Stockholder") at the public offering price of $3.25 per share. The proceeds from the offering to the Selling Stockholder were approximately $10.1 million, before deducting underwriting discounts and commissions. The Company did not sell any shares of its common stock in the offering. The Selling Stockholder received all of the pro

424B7 - SBC Medical Group Holdings Inc (0001930313) (Filer)

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("the Company"), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the "Selling Stockholder") at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company's common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling

424B7 - SBC Medical Group Holdings Inc (0001930313) (Filer)

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026.The Quarterly Update reflects SBC's Q4:25 financial results, ongoing business transition, and outlook for a return to revenue growth in 2026 following pricing-related headwinds experienced during 2025.Key Highlights from the Quarterly Update Report:Revenue Pressure with Expected Recovery: Q4:25 revenue declined year-over-year to approx

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy. The Q&A highlights several key themes, including: Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signa

10-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year